CINXE.COM

Pharmafocus - Magazine Issues

<!DOCTYPE html><html lang="en"><head><link rel="stylesheet" data-href="https://fonts.googleapis.com/css?family=Trade+Gothic+Lt+Bold%7COpen+Sans%7CTrade+Gothic+Lt&amp;display=swap" data-optimized-fonts="true"/><title>Pharmafocus - Magazine Issues</title><link rel="icon" href="https://cdn.magloft.com/pwa-664/pwa/logo/8eb186e1-b2cb-4384-a0b7-515f62171b22.png"/><link rel="shortcut icon" type="image/x-icon" href="https://cdn.magloft.com/pwa-664/pwa/logo/8eb186e1-b2cb-4384-a0b7-515f62171b22.png?optimizer=image&amp;format=webp&amp;width=180&amp;aspectRatio=1"/><link rel="apple-touch-icon" sizes="180x180" href="https://cdn.magloft.com/pwa-664/pwa/logo/8eb186e1-b2cb-4384-a0b7-515f62171b22.png?optimizer=image&amp;format=webp&amp;width=180&amp;aspectRatio=1"/><meta name="application-name" content="Pharmafocus - Magazine Issues"/><meta name="apple-mobile-web-app-capable" content="yes"/><meta name="apple-mobile-web-app-status-bar-style" content="default"/><meta name="apple-mobile-web-app-title" content="Pharmafocus - Magazine Issues"/><meta name="format-detection" content="telephone=no"/><meta name="mobile-web-app-capable" content="yes"/><meta name="msapplication-TileColor" content="#1976D2"/><meta name="msapplication-tap-highlight" content="no"/><link rel="manifest" href="/manifest.json"/><meta name="twitter:url" content="https://www.pharmafocus.com"/><meta name="theme-color" content="#1976D2"/><meta name="viewport" content="width=device-width, initial-scale=1"/><meta charSet="utf-8"/><meta itemProp="name" content="Pharmafocus - Magazine Issues"/><meta itemProp="description" content="Pharmafocus - Magazine Issues"/><meta name="description" content="Pharmafocus - Magazine Issues"/><meta itemProp="image" content="https://cdn.magloft.com/pwa-664/seo/image/b1c374f3-b368-4654-bf00-3b5ed81fe6c2.png"/><meta property="og:description" content="Pharmafocus - Magazine Issues"/><meta property="og:title" content="Pharmafocus - Magazine Issues"/><meta property="og:site_name" content="Pharmafocus - Magazine Issues"/><meta property="og:image" content="https://cdn.magloft.com/pwa-664/seo/image/b1c374f3-b368-4654-bf00-3b5ed81fe6c2.png"/><meta property="og:type" content="website"/><meta name="twitter:card" content="summary_large_image"/><meta name="twitter:title" content="Pharmafocus - Magazine Issues"/><meta name="twitter:description" content="Pharmafocus - Magazine Issues"/><meta name="twitter:image" content="https://cdn.magloft.com/pwa-664/seo/image/b1c374f3-b368-4654-bf00-3b5ed81fe6c2.png"/><meta name="twitter:site" content="@Pharmafocus"/><meta name="twitter:creator" content="@Pharmafocus"/><style>html{--heading-font: &quot;Trade Gothic Lt Bold&quot;;--body-font: &quot;Open Sans&quot;;--ui-font: &quot;Trade Gothic Lt Bold&quot;;--top-menu-title-font: &quot;Trade Gothic Lt Bold&quot;;--top-menu-subtitle-font: &quot;Trade Gothic Lt&quot;;--top-menu-items-font: &quot;Trade Gothic Lt&quot;;--footer-menu-title-font: &quot;Trade Gothic Lt Bold&quot;;--footer-menu-items-font: &quot;Trade Gothic Lt Bold&quot;;--background-color: #FFFFFF;--background-color-dark: #808080;--primary-color: #1976D2;--primary-color-dark: #0C3B69;--secondary-color: #795FF4;--secondary-color-dark: #250B9F;--accent-color: #D76FD6;--accent-color-dark: #80237F;--info-color: #41638C;--info-color-dark: #213246;--warning-color: #EF9338;--warning-color-dark: #89490B;--success-color: #20AD27;--success-color-dark: #105714;--danger-color: #DF4241;--danger-color-dark: #7B1515;--top-menu-background-color: #EE1C25;--top-menu-background-color-dark: #7C090E;--footer-menu-background-color: #DF1111;--footer-menu-background-color-dark: #6F0808;--navbar-height: 64px; }</style><link rel="stylesheet" href="https://cdn.magloft.com/reader/fonts/trade-gothic-lt.css"/><link rel="stylesheet" href="https://cdn.magloft.com/reader/fonts/trade-gothic-lt-bold.css"/><script type="text/javascript" src="https://cdn.jsdelivr.net/npm/cookie-bar/cookiebar-latest.min.js?customize=1&amp;always=1&amp;showNoConsent=1"></script><meta name="google-site-verification" content="kuOvGxaH_NjG3aS7GSmbjjV-OjdOAWyiM3gEPGESeHQ"/><style> #billboard-banner { text-align:center;} #billboard-banner img {width:100%; max-width:970px; height:auto; position:relative; top:70px;} .Layout_spacer__qTBD3 {margin-top:70px;} </style><meta name="next-head-count" content="39"/><link rel="preconnect" href="https://fonts.googleapis.com"/><link rel="preconnect" href="https://fonts.gstatic.com"/><link rel="preload" href="/_next/static/css/229efe2956472d85.css" as="style"/><link rel="stylesheet" href="/_next/static/css/229efe2956472d85.css" data-n-g=""/><link rel="preload" href="/_next/static/css/5dcc38b90034d324.css" as="style"/><link rel="stylesheet" href="/_next/static/css/5dcc38b90034d324.css" data-n-p=""/><noscript data-n-css=""></noscript><script defer="" nomodule="" src="/_next/static/chunks/polyfills-c67a75d1b6f99dc8.js"></script><script defer="" src="https://fonts.googleapis.com/css?family=Open+Sans&amp;display=swap" data-nscript="beforeInteractive"></script><script src="/_next/static/chunks/webpack-b653c683a51d8b57.js" defer=""></script><script src="/_next/static/chunks/framework-73b8966a3c579ab0.js" defer=""></script><script src="/_next/static/chunks/main-34cb81d5753e1fc4.js" defer=""></script><script src="/_next/static/chunks/pages/_app-6805a2020fbcfa43.js" defer=""></script><script src="/_next/static/chunks/655-d6e1933688b2da2a.js" defer=""></script><script src="/_next/static/chunks/pages/domains/%5Bdomain%5D/categories/%5Bslug%5D-06ee3613a207102c.js" defer=""></script><script src="/_next/static/U1LT7ce93wR6IyWFJCllT/_buildManifest.js" defer=""></script><script src="/_next/static/U1LT7ce93wR6IyWFJCllT/_ssgManifest.js" defer=""></script><style data-styled="" data-styled-version="5.3.9"></style><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Trade+Gothic+Lt+Bold%7COpen+Sans%7CTrade+Gothic+Lt&display=swap"/></head><body><div id="__next"><div class="Layout_container__gktH6"><div class="Layout_navbar-container__gCfDZ" style="height:64px"><nav class="_wrapper_jbnbd_1"><div class="_container_jbnbd_15"><a class="_navbar-brand_jbnbd_29" aria-label="Pharmafocus" href="/"><div class="_navbar-image_jbnbd_40"><img alt="Logo" loading="lazy" decoding="async" data-nimg="fill" class="_image_jbnbd_43" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent" sizes="100vw" srcSet="https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 54w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 70w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 82w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 96w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 110w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 128w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 138w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 192w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 200w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 252w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 260w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 298w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 378w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 384w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 520w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 640w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 756w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 828w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 1080w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 1200w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 1920w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 2048w" src="https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png"/></div><div class="_navbar-title_jbnbd_58 _navbar-title-hide_jbnbd_101"></div></a><div id="navbar-children-container" class="_navbar-children_jbnbd_116"><div class="_menu_1jhrl_1"><div class="_menu-wrapper_1jhrl_22"><div class="_menu-items_1jhrl_38"><a class="_menu-item_1jhrl_38" href="/"><div class="_menu-home_1lm7t_255 _menu-item-icon_1jhrl_97 _icon_1lm7t_1 icon"></div><div class="_menu-item-title_1jhrl_88">Home</div><div class="_indicator_1jhrl_63"></div></a><a class="_menu-item_1jhrl_38" href="/articles"><div class="_menu-articles_1lm7t_259 _menu-item-icon_1jhrl_97 _icon_1lm7t_1 icon"></div><div class="_menu-item-title_1jhrl_88">Articles</div><div class="_indicator_1jhrl_63"></div></a><a class="_menu-item_1jhrl_38 _active_1jhrl_70" href="/collections"><div class="_menu-issues_1lm7t_263 _menu-item-icon_1jhrl_97 _icon_1lm7t_1 icon"></div><div class="_menu-item-title_1jhrl_88">Magazines</div><div class="_indicator_1jhrl_63 _active_1jhrl_70"></div></a><a class="_menu-item_1jhrl_38" href="/account/login"><div class="_menu-account_1lm7t_411 _menu-item-icon_1jhrl_97 _icon_1lm7t_1 icon"></div><div class="_menu-item-title_1jhrl_88">Log in</div><div class="_indicator_1jhrl_63"></div></a></div></div></div></div><div id="navbar-suffix" class="_navbar-suffix_jbnbd_108"><div class="Layout_menu-actions__vsDbI"><div class="Layout_install-button__FBfSr"><div class="Tooltip_tooltip__98Sw9"></div><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button" style="color:var(--top-menu-item-icon-color, var(--background-color))" role="button" aria-label="Search" aria-labelledby="labeldiv" title="Search"><div class="_action-search_1lm7t_15 _icon-button_19h3g_19 _icon_1lm7t_1 icon" style="background-color:var(--top-menu-item-icon-color, var(--background-color))"></div></button></div></div></div></div></nav></div><div class="Layout_main__evUHx"><div class="Layout_spacer__qTBD3" style="height:64px"></div><div class="_slug__wrapper__ruU0S"><div class="_slug__category-header__7cydo"><img alt="Issue Cover" loading="lazy" width="128" height="128" decoding="async" data-nimg="1" class="_slug__category-image___YpSr" style="color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 128 128&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" srcSet="https://media.magloft.app/pwa-664/category/image/73869308-54b9-43d7-acf9-fdafa1d07e63.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1 1x, https://media.magloft.app/pwa-664/category/image/73869308-54b9-43d7-acf9-fdafa1d07e63.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1 2x" src="https://media.magloft.app/pwa-664/category/image/73869308-54b9-43d7-acf9-fdafa1d07e63.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1"/><h2>Clinical Trials</h2><p>Latest updates on clinical trials and their results.</p></div><div style="height:auto" class="BlockHeader_block-header__JmokO"><div class="BlockHeader_container-title__l5lHB"><h2 style="border-bottom-color:#444444">Collections</h2></div></div><div class="IssueList_wrapper__cNptl"><div class="infinite-scroll-component__outerdiv"><div class="infinite-scroll-component " style="height:auto;overflow:visible;-webkit-overflow-scrolling:touch"><div class="IssueList_container__tG81k"><div class="_card_1s1n3_1 card raised interactive"><div class="_card-body_1s1n3_12 card-body"><div class="_issue-cover_1s1n3_17"><a href="/collections/pharmafocus-october-2024"><img alt="issue-item" loading="lazy" width="768" height="1024" decoding="async" data-nimg="1" style="color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 768 1024&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="(min-width: 796px) 200px, (min-width: 601px) 252px, 192px" srcSet="https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=16 16w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=32 32w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=48 48w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=54 54w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=64 64w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=70 70w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=82 82w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=96 96w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=96 96w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=110 110w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=128 128w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=128 128w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=138 138w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=192 192w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=200 200w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=252 252w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=256 256w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=260 260w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=298 298w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=378 378w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=384 384w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=384 384w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=520 520w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=640 640w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=756 756w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=828 828w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1080 1080w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1200 1200w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1920 1920w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=2048 2048w" src="https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=2048"/></a></div><div class="_issue-detail_1s1n3_27"><div class="_issue-detail-header_1s1n3_33"><div class="_card-date_1s1n3_39"><a href="/collections/pharmafocus-october-2024"><span>UK News<!-- --> </span>10 October 2024</a></div></div><div class="_issue-detail-content_1s1n3_52"><div><a href="/collections/pharmafocus-october-2024"><p class="_card-title_1s1n3_56">Pharmafocus October 2024</p><p class="_description_1s1n3_67">Welcome to the October 2024 edition of Pharmafocus!</p></a></div></div><div class="_issue-action-wrapper_1s1n3_79"><a href="/collections/pharmafocus-october-2024"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _primary_19h3g_15" type="button" role="button" aria-label="Pending" aria-labelledby="labeldiv">...</button></a></div></div></div></div><div class="_card_1s1n3_1 card raised interactive"><div class="_card-body_1s1n3_12 card-body"><div class="_issue-cover_1s1n3_17"><a href="/collections/pharmafocus-september-2024"><img alt="issue-item" loading="lazy" width="768" height="1024" decoding="async" data-nimg="1" style="color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 768 1024&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="(min-width: 796px) 200px, (min-width: 601px) 252px, 192px" srcSet="https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=16 16w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=32 32w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=48 48w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=54 54w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=64 64w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=70 70w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=82 82w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=96 96w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=96 96w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=110 110w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=128 128w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=128 128w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=138 138w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=192 192w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=200 200w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=252 252w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=256 256w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=260 260w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=298 298w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=378 378w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=384 384w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=384 384w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=520 520w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=640 640w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=756 756w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=828 828w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1080 1080w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1200 1200w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1920 1920w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=2048 2048w" src="https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=2048"/></a></div><div class="_issue-detail_1s1n3_27"><div class="_issue-detail-header_1s1n3_33"><div class="_card-date_1s1n3_39"><a href="/collections/pharmafocus-september-2024"><span>UK News<!-- --> </span>5 September 2024</a></div></div><div class="_issue-detail-content_1s1n3_52"><div><a href="/collections/pharmafocus-september-2024"><p class="_card-title_1s1n3_56">Pharmafocus September 2024</p><p class="_description_1s1n3_67">Welcome to the September 2024 issue of Pharmafocus! This issue covers the latest news including new FDA approval for primary biliary cholangitis, NICE recommendations for skyrizi (risankizumab), CHMP opinion on Merck’s KEYTRUDA, as well as articles on precision medicine and oral peptides PLUS what to look out for at this year&#x27;s CPHI in Milan! </p></a></div></div><div class="_issue-action-wrapper_1s1n3_79"><a href="/collections/pharmafocus-september-2024"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _primary_19h3g_15" type="button" role="button" aria-label="Pending" aria-labelledby="labeldiv">...</button></a></div></div></div></div></div></div></div></div><div style="height:auto" class="BlockHeader_block-header__JmokO"><div class="BlockHeader_container-title__l5lHB"><h2 style="border-bottom-color:#444444">Articles</h2></div></div><div class="ArticleList_wrapper__T0ntw"><div class="infinite-scroll-component__outerdiv"><div class="infinite-scroll-component " style="height:auto;overflow:visible;-webkit-overflow-scrolling:touch"><div class="ArticleList_container__ln6vK"><a class="_card_n1ew6_1" href="/articles/aravax-successfully-recruits-for-phase-3-peanut-allergy-treatmen-0fe6"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 86 64.5&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=16 16w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=32 32w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=48 48w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=54 54w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=64 64w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=70 70w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=82 82w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=110 110w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=138 138w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=192 192w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=200 200w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=252 252w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=256 256w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=260 260w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=298 298w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=378 378w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=520 520w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=640 640w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=756 756w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=828 828w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1080 1080w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1200 1200w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1920 1920w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">Aravax successfully recruits for phase 3 peanut allergy treatment study</span><p class="">Clinical-stage biotech company Aravax has announced that it has completed phase 2 recruitment for its precision therapy (pvx108) study, which investigates treatment of peanut allergies.</p><div class="_card-date_n1ew6_142">15 November 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">Clinical Trials</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/chiesi-announces-phase-3-results-from-enzyme-replacement-study-c996"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 86 64.5&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=16 16w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=32 32w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=48 48w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=54 54w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=64 64w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=70 70w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=82 82w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=110 110w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=138 138w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=192 192w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=200 200w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=252 252w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=256 256w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=260 260w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=298 298w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=378 378w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=520 520w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=640 640w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=756 756w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=828 828w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1080 1080w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1200 1200w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1920 1920w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">Chiesi announces phase 3 results from enzyme-replacement study</span><p class="">Chiesi Global Rare Diseases has announced the results from its BRIGHT trial, which evaluates the efficacy of enzyme-replacement therapy drug elfabrio at twice the approved dose in patients who have been treated with agalsidase alfa or beta. The current approved dose of pegunigalside alfa-iwxj (elfabrio) is 1 milligram (mg) per kilogram (kg) administered every two weeks.</p><div class="_card-date_n1ew6_142">15 November 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">Clinical Trials</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/valiant-phase-3-trial-results-highlight-potential-treatment-for-f577"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 86 64.5&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=16 16w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=32 32w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=48 48w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=54 54w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=64 64w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=70 70w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=82 82w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=110 110w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=138 138w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=192 192w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=200 200w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=252 252w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=256 256w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=260 260w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=298 298w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=378 378w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=520 520w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=640 640w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=756 756w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=828 828w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1080 1080w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1200 1200w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1920 1920w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048 2048w" src="https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">VALIANT phase 3 trial results highlight potential treatment for rare kidney diseases</span><p class="">Sobi and Apellis Pharmaceuticals have announced the results from the VALIANT trial, which highlight that systemic pegcetacoplan treatment could benefit patients with c3 glomerulopathy (c3g) and primary immune complex membranoproliferative glomerulonephritis (ic-mpgn).</p><div class="_card-date_n1ew6_142">15 November 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">Clinical Trials</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/rallybio-s-application-for-a-phase-2-trial-in-pregnant-women-app-1387"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 86 64.5&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=16 16w, https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=32 32w, https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=48 48w, https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=54 54w, https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=64 64w, https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=70 70w, https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=82 82w, https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=110 110w, https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=138 138w, https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=192 192w, https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=200 200w, https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=252 252w, https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=256 256w, https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=260 260w, https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=298 298w, https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=378 378w, https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=520 520w, https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=640 640w, https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=756 756w, https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=828 828w, https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1080 1080w, https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1200 1200w, https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1920 1920w, https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_11-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">Rallybio’s application for a phase 2 trial in pregnant women approved</span><p class="">Clinical-stage biotech company Rallybio corporation has announced that it has received approval from two regulatory bodies for its clinical trial applications (CTAS) for a phase 2 study involving pregnant women.</p><div class="_card-date_n1ew6_142">15 November 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">Clinical Trials</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/verisense-announce-opening-of-digital-biobank"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 86 64.5&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=16 16w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=32 32w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=48 48w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=54 54w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=64 64w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=70 70w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=82 82w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=110 110w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=138 138w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=192 192w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=200 200w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=252 252w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=256 256w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=260 260w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=298 298w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=378 378w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=520 520w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=640 640w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=756 756w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=828 828w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1080 1080w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1200 1200w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1920 1920w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048 2048w" src="https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">Verisense announce opening of Digital Biobank</span><p class="">This month, Verisense have announced that their digital biobank, with data from over one million people, is open for business.</p><div class="_card-date_n1ew6_142">5 September 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">UK News</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/dive-into-the-heart-of-pharma-at-cphi-milan-2024"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 86 64.5&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=16 16w, https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=32 32w, https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=48 48w, https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=54 54w, https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=64 64w, https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=70 70w, https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=82 82w, https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=110 110w, https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=138 138w, https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=192 192w, https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=200 200w, https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=252 252w, https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=256 256w, https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=260 260w, https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=298 298w, https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=378 378w, https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=520 520w, https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=640 640w, https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=756 756w, https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=828 828w, https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1080 1080w, https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1200 1200w, https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1920 1920w, https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048 2048w" src="https://media.magloft.app/pdf-import/1110/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">Dive into the heart of pharma at CPHI Milan 2024</span><p class="">Join us at CPHI Milan 2024, the premier global event for pharmaceutical professionals, from 8-10 October at Fiera Milano, Milan, Italy. Celebrating 35 years of excellence, this event promises unparalleled opportunities for networking, innovation and professional growth. With over 62,000 attendees and 2,500 exhibitors, you’ll experience insightful seminars, cutting-edge exhibitions and new awards such as ‘Woman of the Year’ and ‘Future Leader’. </p><div class="_card-date_n1ew6_142">5 September 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">UK News</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/fda-approves-skin-cancer-ai-detection-device"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 86 64.5&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=16 16w, https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=32 32w, https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=48 48w, https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=54 54w, https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=64 64w, https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=70 70w, https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=82 82w, https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=110 110w, https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=138 138w, https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=192 192w, https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=200 200w, https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=252 252w, https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=256 256w, https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=260 260w, https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=298 298w, https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=378 378w, https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=520 520w, https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=640 640w, https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=756 756w, https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=828 828w, https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1080 1080w, https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1200 1200w, https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1920 1920w, https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048 2048w" src="https://media.magloft.app/pdf-import/1002/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">FDA approves skin cancer AI detection device</span><p class="">DermaSensor has announced that the FDA has granted clearance for its real-time, non-invasive skin cancer evaluation system.</p><div class="_card-date_n1ew6_142">7 February 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">Clinical Trials</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/digital-healthcare-platform-launched-by-eli-lilly"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 86 64.5&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=16 16w, https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=32 32w, https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=48 48w, https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=54 54w, https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=64 64w, https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=70 70w, https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=82 82w, https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=110 110w, https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=138 138w, https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=192 192w, https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=200 200w, https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=252 252w, https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=256 256w, https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=260 260w, https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=298 298w, https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=378 378w, https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=520 520w, https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=640 640w, https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=756 756w, https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=828 828w, https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1080 1080w, https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1200 1200w, https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1920 1920w, https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048 2048w" src="https://media.magloft.app/pdf-import/1002/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">Digital healthcare platform launched by Eli Lilly</span><p class="">Eli Lilly has announced its new digital healthcare experience, LillyDirect, which will benefit patients in the US with obesity, migraine and diabetes. This is intended to offer resources around disease management, such as access to healthcare providers, tailored support and delivery of selected medications.</p><div class="_card-date_n1ew6_142">7 February 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">Clinical Trials</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/nice-recommends-nine-digital-treatment-options-for-depression-and-anxiety"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 86 64.5&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=16 16w, https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=32 32w, https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=48 48w, https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=54 54w, https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=64 64w, https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=70 70w, https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=82 82w, https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=110 110w, https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=138 138w, https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=192 192w, https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=200 200w, https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=252 252w, https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=256 256w, https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=260 260w, https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=298 298w, https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=378 378w, https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=520 520w, https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=640 640w, https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=756 756w, https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=828 828w, https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1080 1080w, https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1200 1200w, https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1920 1920w, https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048 2048w" src="https://media.magloft.app/pdf-import/850/images/img_2-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">NICE recommends nine digital treatment options for depression and anxiety</span><p class="">The National Institute for Health and Care Excellence (NICE) has recommended six digitally enabled therapies for adult patients with anxiety disorders and three digitally enabled therapies for adult patients with depression for use within the NHS while further data is gathered.</p><div class="_card-date_n1ew6_142">2 July 2023<span class="_category-chip_n1ew6_155" style="background-color:#444444">Clinical Trials</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/servier-and-aitia-enter-into-r-d-collaboration-for-pancreatic-ca"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 86 64.5&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=16 16w, https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=32 32w, https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=48 48w, https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=54 54w, https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=64 64w, https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=70 70w, https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=82 82w, https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=110 110w, https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=138 138w, https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=192 192w, https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=200 200w, https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=252 252w, https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=256 256w, https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=260 260w, https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=298 298w, https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=378 378w, https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=520 520w, https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=640 640w, https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=756 756w, https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=828 828w, https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1080 1080w, https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1200 1200w, https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1920 1920w, https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048 2048w" src="https://media.magloft.app/pdf-import/850/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">Servier and Aitia enter into R&amp;D collaboration for pancreatic cancer using Digital Twins</span><p class="">French pharmaceutical company Servier and US-based causal AI and digital twins company Aitia have announced a collaboration to create digital twins as an aid to help treat pancreatic cancer. This collaboration builds on a previous multiple myeloma one that was announced in 2022.</p><div class="_card-date_n1ew6_142">2 July 2023<span class="_category-chip_n1ew6_155" style="background-color:#444444">Clinical Trials</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/bristol-myers-squibb-and-viz-ai-sign-multi-year-partnership-for"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 86 64.5&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=16 16w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=32 32w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=48 48w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=54 54w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=64 64w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=70 70w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=82 82w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=110 110w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=138 138w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=192 192w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=200 200w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=252 252w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=256 256w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=260 260w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=298 298w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=378 378w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=520 520w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=640 640w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=756 756w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=828 828w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1080 1080w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1200 1200w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1920 1920w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048 2048w" src="https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">Bristol Myers Squibb and Viz.ai sign multi-year partnership for HCM device</span><p class="">Bristol Myers Squibb and Viz.ai, an AI-powered medical imaging company, have signed a deal to use AI to detect and triage patients with suspected hypertrophic cardiomyopathy (hcm).</p><div class="_card-date_n1ew6_142">2 April 2023<span class="_category-chip_n1ew6_155" style="background-color:#444444">Clinical Trials</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/sooma-receives-fda-breakthrough-device-designation-for-depressio"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 86 64.5&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=16 16w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=32 32w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=48 48w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=54 54w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=64 64w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=70 70w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=82 82w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=110 110w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=138 138w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=192 192w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=200 200w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=252 252w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=256 256w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=260 260w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=298 298w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=378 378w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=520 520w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=640 640w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=756 756w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=828 828w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1080 1080w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1200 1200w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1920 1920w, https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048 2048w" src="https://media.magloft.app/pdf-import/771/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">Sooma receives FDA Breakthrough Device designation for depression therapy device</span><p class="">Finnish company Sooma medical has received breakthrough device designation by the FDA for its portable, at-home neuromodulation device to treat depression.</p><div class="_card-date_n1ew6_142">2 April 2023<span class="_category-chip_n1ew6_155" style="background-color:#444444">Clinical Trials</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a></div></div></div></div></div></div><script> //create a new element const terms = document.createElement('div'); //set id terms.setAttribute("id","billboard-banner"); //add the new element to html var body = document.querySelector('body'); body.appendChild(terms); document.querySelector("#billboard-banner").innerHTML = "<ins data-revive-zoneid='1573' data-revive-id='9c421b7e485bf2edfee09708a4d06e2e'></ins>"; //insert new element before header //document.body.insertAdjacentElement('afterbegin', terms); const insElement = document.querySelector("#__next"); insElement.before(terms); </script> <script async="" src="//ads.datateam.co.uk/www/delivery/asyncjs.php"></script><div class="_footer_j8nu5_1"><div class="_container_j8nu5_12"><div class="_footer-row_j8nu5_23"><div class="_footer-column_j8nu5_36 _flex-2_j8nu5_117"><div class="_footer-brand_j8nu5_43"><div class=""><img alt="Logo" loading="lazy" width="40" height="40" decoding="async" data-nimg="1" class="_footer-logo_j8nu5_57" style="color:transparent" srcSet="https://media.magloft.app/pwa-664/pwa/logo/8eb186e1-b2cb-4384-a0b7-515f62171b22.png 1x, https://media.magloft.app/pwa-664/pwa/logo/8eb186e1-b2cb-4384-a0b7-515f62171b22.png 2x" src="https://media.magloft.app/pwa-664/pwa/logo/8eb186e1-b2cb-4384-a0b7-515f62171b22.png"/></div><div class="_content_j8nu5_67"><h3>Pharmafocus</h3><p>Pharmaceutical Industry news, analysis and insights</p></div></div><div class="_footer-link-list_j8nu5_121"><div class="_block_j8nu5_129"><a class="_footer-link-item_j8nu5_92" rel="noreferrer" href="mailto:info@pharmafile.com"><div class="_form-email_1lm7t_143 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span>info@pharmafile.com</span></a></div><div class="_block_j8nu5_129"><a class="_footer-link-item_j8nu5_92" target="_blank" rel="noreferrer" href="http://www.pharmafile.com"><div class="_status-info_1lm7t_87 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span>Pharmafile.com</span></a><a class="_footer-link-item_j8nu5_92" target="_blank" rel="noreferrer" href="https://magazine.pharmafile.com"><div class="_status-info_1lm7t_87 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span>Pharmafile Magazine</span></a><a class="_footer-link-item_j8nu5_92" target="_blank" rel="noreferrer" href="http://www.samedanltd.com"><div class="_status-info_1lm7t_87 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span>Samedan</span></a></div><a target="_blank" rel="noreferrer" class="_footer-link-item_j8nu5_92" href="https://www.pharmafile.com/privacy-policy"><div class="_status-info_1lm7t_87 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span>Privacy Policy</span></a><a target="_blank" rel="noreferrer" class="_footer-link-item_j8nu5_92" href="https://www.pharmafile.com/terms-of-service"><div class="_status-info_1lm7t_87 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span>Terms of Service</span></a></div></div><div class="_footer-column_j8nu5_36 _flex-1_j8nu5_39"><div class="_footer-brand_j8nu5_43"><div class="_status-accent_1lm7t_91 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><div class="_content_j8nu5_67"><h3>Categories</h3><p>Explore our inspiring content by topic</p></div></div><div class="_footer-link-list_j8nu5_121"><a class="_footer-link-item_j8nu5_92" href="/categories/uk-pharma-news"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>UK News</a><a class="_footer-link-item_j8nu5_92" href="/categories/general-news"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>General News</a><a class="_footer-link-item_j8nu5_92" href="/categories/approvals"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>Approvals</a><a class="_footer-link-item_j8nu5_92" href="/categories/research-and-development"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>R &amp; D</a><a class="_footer-link-item_j8nu5_92" href="/categories/mergers-acquisitions"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>Mergers &amp; Acquisitions</a><a class="_footer-link-item_j8nu5_92" href="/categories/manufacturing-production"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>Manufacturing</a><a class="_footer-link-item_j8nu5_92" href="/categories/clinical-trials"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>Clinical Trials</a><a class="_footer-link-item_j8nu5_92" href="/categories/industry-insights"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>Industry Insights</a><a class="_footer-link-item_j8nu5_92" href="/categories/appointments"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>Appointments</a><a class="_footer-link-item_j8nu5_92" href="/categories/insider-interviews"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>Interviews</a></div></div><div class="_footer-column_j8nu5_36 _flex-1_j8nu5_39"><div class="_footer-brand_j8nu5_43"><div class="_share-action_1lm7t_463 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><div class="_content_j8nu5_67"><h3>Social Footprints</h3><p>Follow us on our Social Media Channels</p></div></div><div class="_footer-link-list_j8nu5_121"><a class="_footer-link-item_j8nu5_92" target="_blank" rel="noreferrer" href="https://twitter.com/Pharmafocus"><div class="_share-twitter_1lm7t_487 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span class="_footer-text_j8nu5_125">X</span></a><a class="_footer-link-item_j8nu5_92" target="_blank" rel="noreferrer" href="https://www.linkedin.com/company/pharmafile"><div class="_share-linkedin_1lm7t_483 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span class="_footer-text_j8nu5_125">linkedin</span></a></div></div></div></div></div></div><div class="Toastify"></div></div><script id="__NEXT_DATA__" type="application/json">{"props":{"pageProps":{"domain":"www.pharmafocus.com","pwa":{"id":664,"publicationId":14882,"pwaOptinId":656,"domain":"www.pharmafocus.com","config":{"access":{"concurrentLimit":null,"restrictAnonymous":null,"disableSignup":null,"disableLogin":null,"disableLoginMessage":null,"disableSearchIndexing":false,"signupUrl":null,"resetPasswordUrl":null,"isUsernameLogin":null,"disableEditProfile":null,"formUrl":null,"customMarginResetPassword":null},"push":{"google":{"serverPublicKey":"BGfKWie38SRvrZs4-bDa1N70rhULMBqX8nAvBZT_2OXsMQi3uRA0CaK4JKPuib9Ega28liCTGhBx0QCY4t1QU7o"}},"tracking":{"facebook":{"appId":null,"pixelId":null},"google":{"measurementId":"G-D8QLP3CKWG"},"gtm":null,"sentry":true},"payment":{"stripe":null,"bypassPayment":null,"mode":"none","external":null,"currency":null},"email":{"readerOptin":false},"firebase":{"projectId":"ipt-magloft","senderId":"497261264876","pairKey":null,"webAppConfig":{"apiKey":"AIzaSyBcHBC8k394YdXp19dZj2Xqe8CXCgThBZs","appId":"1:497261264876:web:98452398b320341bd68ac9","authDomain":"ipt-magloft.firebaseapp.com","databaseURL":null,"locationId":null,"messagingSenderId":"497261264876","projectId":"ipt-magloft","storageBucket":"ipt-magloft.appspot.com"}},"customHtml":{"head":"\u003cscript type=\"text/javascript\" src=\"https://cdn.jsdelivr.net/npm/cookie-bar/cookiebar-latest.min.js?customize=1\u0026always=1\u0026showNoConsent=1\" onload=\"setupCookieBar();\"\u003e\u003c/script\u003e\n\u003cmeta name=\"google-site-verification\" content=\"kuOvGxaH_NjG3aS7GSmbjjV-OjdOAWyiM3gEPGESeHQ\" /\u003e\n\u003cstyle\u003e\n#billboard-banner { text-align:center;}\n#billboard-banner img {width:100%; max-width:970px; height:auto; position:relative; top:70px;}\n.Layout_spacer__qTBD3 {margin-top:70px;}\n\u003c/style\u003e","body":"\u003cscript\u003e\n //create a new element\n const terms = document.createElement('div');\n //set id\n terms.setAttribute(\"id\",\"billboard-banner\");\n //add the new element to html\n var body = document.querySelector('body');\n body.appendChild(terms);\n document.querySelector(\"#billboard-banner\").innerHTML = \"\u003cins data-revive-zoneid='1573' data-revive-id='9c421b7e485bf2edfee09708a4d06e2e'\u003e\u003c/ins\u003e\"; \n //insert new element before header\n//document.body.insertAdjacentElement('afterbegin', terms);\n const insElement = document.querySelector(\"#__next\");\n insElement.before(terms);\n\u003c/script\u003e\n\u003cscript async src=\"//ads.datateam.co.uk/www/delivery/asyncjs.php\"\u003e\u003c/script\u003e"},"account":{"emailEditable":true,"customSubscriptionText":null,"customSubscriptionURL":null,"enableSubscriptionTitle":null},"checkout":null},"design":{"colors":{"backgroundColor":"#FFFFFF","primaryColor":"#1976D2","secondaryColor":"#795FF4","accentColor":"#D76FD6","infoColor":"#41638C","warningColor":"#EF9338","successColor":"#20AD27","dangerColor":"#DF4241","topMenuBackgroundColor":"#EE1C25","topMenuHeadingTitleColor":null,"topMenuHeadingIconColor":null,"topMenuItemTextColor":null,"topMenuItemIconColor":null,"footerMenuBackgroundColor":"#DF1111","footerMenuHeadingTitleColor":null,"footerMenuHeadingTextColor":null,"footerMenuHeadingIconColor":null,"footerMenuItemTextColor":null,"footerMenuItemIconColor":null},"images":{"icon":"https://cdn.magloft.com/pwa-664/pwa/logo/8eb186e1-b2cb-4384-a0b7-515f62171b22.png","feature":"https://cdn.magloft.com/defaults/feature-graphic.jpg","topMenuIcon":"https://cdn.magloft.com/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png","footerMenuIcon":null,"alphaChannelIcon":null},"fonts":{"heading":"trade-gothic-lt-bold","body":"open-sans","ui":"trade-gothic-lt-bold","topMenuTitle":"trade-gothic-lt-bold","topMenuItems":"trade-gothic-lt","topMenuSubtitle":"trade-gothic-lt","footerMenuTitle":null,"footerMenuItems":null},"menuItems":{"collections":{"title":"Magazines"},"articles":{"title":null},"account":{"title":null},"icons":{"enabled":true}},"footerShape":"flat","issueCoverAspectRatio":0.75,"fullscreenCollectionView":"auto","customOverlayToggleView":false,"defaultViewMode":"html","categories":"flat","purchaseList":true,"libraryList":false,"noteList":false,"textToSpeech":false},"layout":{"banners":[{"image":"https://cdn.magloft.com/pwa-1/pwa/banner/aea74608-e04a-4649-b817-c45cc439e28e.png","title":"Start trial now","isHidden":true,"action":{"type":"url","href":"https://www.magloft.com/","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}}],"bottomBanners":[{"image":"https://cdn.magloft.com/pwa-664/pwa/banner/1f66e6ea-9b3a-4477-aba1-18abf54619b8.png","title":null,"isHidden":true,"action":{"type":"url","href":"http://www.samedanltd.com/","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}}],"columnSeparator":"shadow","tabs":[{"route":"","title":"Home","icon":"menu-home","visible":true},{"route":"/articles","title":"Articles","icon":"menu-articles","visible":true},{"route":"/collections","title":"Collections","icon":"menu-issues","visible":true},{"route":"/account","title":"Account","icon":"menu-account","visible":true}],"topMenu":{"showLogo":true,"showSubtitle":false,"showTitle":false,"height":"64px"},"navbar":{"animation":false,"style":"logo-left"},"sections":[{"fullWidth":true,"backgroundColor":"transparent","columnSeparator":"none","columns":[{"size":5,"blocks":[{"type":"banner","image":"https://cdn.magloft.com/pwa-1/pwa/banner/aea74608-e04a-4649-b817-c45cc439e28e.png","isHidden":true,"title":"Start trial now","action":{"type":"url","href":"https://www.magloft.com/","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}}]}]},{"fullWidth":false,"backgroundColor":null,"columnSeparator":"shadow","columns":[{"size":8.5,"blocks":[{"type":"ad","title":"Advertisement","advertisementIds":[],"adCampaignId":892,"condition":null},{"type":"article-list","condition":null,"color":"#F90505","title":"Top Content","variant":"variant-b","articleIds":[262748,254614,260494,260493,260492,258749],"articles":null},{"type":"article-list","condition":null,"color":"#2873B0","title":"Industry Insights","variant":"variant-b","articleIds":[260492,260493,260494,258746,258745,257361],"articles":null},{"type":"article-category","condition":null,"color":"#F90505","title":"UK News","variant":"variant-c","categoryId":43138,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"article-category","condition":null,"color":"#2873B0","title":"Global News","variant":"variant-c","categoryId":43140,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"ad","title":"Advertisement","advertisementIds":[1319],"adCampaignId":null,"condition":null},{"type":"article-category","condition":null,"color":"#2873B0","title":"European News","variant":"variant-c","categoryId":43139,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"guide-install","color":"#444558","title":"How to Install","condition":null}]},{"size":3.5,"blocks":[{"type":"issue-slider","condition":null,"color":"#2873B0","title":"Latest Editions","issueIds":[52826,52799,52483,52217,51921,51722,51533,51435,51240,51075,45938,45939,45940],"thumbnail":{"style":"full-cover","size":"medium"},"borderRadius":null,"zoomOnHover":true,"issues":null},{"type":"ad","title":"Advertisement","advertisementIds":[2210],"adCampaignId":null,"condition":null},{"type":"cta","condition":null,"icon":"symbol-gift","color":"#FB0505","title":"Newsletters","description":"Sign up to our newsletters and digital magazines","action":{"type":"url","href":"https://curwoodcmsltd.formstack.com/forms/samedan","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}},{"type":"ad","title":"Advertisement","advertisementIds":[2067],"adCampaignId":null,"condition":null},{"type":"cta","condition":null,"icon":"symbol-day","color":"#F90505","title":"Pharmafocus Archive","description":"Browse older editions","action":{"type":"url","href":"https://en.calameo.com/subscriptions/6188508","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}},{"type":"ad","title":"Advertisement","advertisementIds":[],"adCampaignId":1044,"condition":null},{"type":"article-category","condition":null,"color":"#F70707","title":"Appointments","variant":"variant-c","categoryId":43146,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"ad","title":"Advertisement","advertisementIds":[2249,1320],"adCampaignId":null,"condition":null}]}]},{"fullWidth":true,"backgroundColor":"transparent","columnSeparator":"none","columns":[{"size":5,"blocks":[{"type":"banner","image":"https://cdn.magloft.com/pwa-664/pwa/banner/1f66e6ea-9b3a-4477-aba1-18abf54619b8.png","isHidden":true,"title":"","action":{"type":"url","href":"http://www.samedanltd.com/","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}}]}]}],"columns":[{"size":8.5,"blocks":[{"type":"ad","title":"Advertisement","advertisementIds":[],"adCampaignId":892,"condition":null},{"type":"article-list","condition":null,"color":"#F90505","title":"Top Content","variant":"variant-b","articleIds":[262748,254614,260494,260493,260492,258749],"articles":null},{"type":"article-list","condition":null,"color":"#2873B0","title":"Industry Insights","variant":"variant-b","articleIds":[260492,260493,260494,258746,258745,257361],"articles":null},{"type":"article-category","condition":null,"color":"#F90505","title":"UK News","variant":"variant-c","categoryId":43138,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"article-category","condition":null,"color":"#2873B0","title":"Global News","variant":"variant-c","categoryId":43140,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"ad","title":"Advertisement","advertisementIds":[1319],"adCampaignId":null,"condition":null},{"type":"article-category","condition":null,"color":"#2873B0","title":"European News","variant":"variant-c","categoryId":43139,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"guide-install","color":"#444558","title":"How to Install","condition":null}]},{"size":3.5,"blocks":[{"type":"issue-slider","condition":null,"color":"#2873B0","title":"Latest Editions","issueIds":[52826,52799,52483,52217,51921,51722,51533,51435,51240,51075,45938,45939,45940],"thumbnail":{"style":"full-cover","size":"medium"},"borderRadius":null,"zoomOnHover":true,"issues":null},{"type":"ad","title":"Advertisement","advertisementIds":[2210],"adCampaignId":null,"condition":null},{"type":"cta","condition":null,"icon":"symbol-gift","color":"#FB0505","title":"Newsletters","description":"Sign up to our newsletters and digital magazines","action":{"type":"url","href":"https://curwoodcmsltd.formstack.com/forms/samedan","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}},{"type":"ad","title":"Advertisement","advertisementIds":[2067],"adCampaignId":null,"condition":null},{"type":"cta","condition":null,"icon":"symbol-day","color":"#F90505","title":"Pharmafocus Archive","description":"Browse older editions","action":{"type":"url","href":"https://en.calameo.com/subscriptions/6188508","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}},{"type":"ad","title":"Advertisement","advertisementIds":[],"adCampaignId":1044,"condition":null},{"type":"article-category","condition":null,"color":"#F70707","title":"Appointments","variant":"variant-c","categoryId":43146,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"ad","title":"Advertisement","advertisementIds":[2249,1320],"adCampaignId":null,"condition":null}]}]},"seo":{"home":{"title":"Pharmafocus Magazine - covering pharma and biotech since 1986","description":"Reporting on the pharma industry, drug development \u0026 clinical trials, manufacturing, logistics, market access, and patients.\nFrom breaking stories to interviews with senior executives, we look at regulations \u0026 trends to provide useful market intelligence.","image":"https://cdn.magloft.com/pwa-664/seo/image/270800d8-b1de-41b8-86ad-5d262d2b9adf.png","imageAlt":"Pharmafocus Magazine"},"articles":{"title":"Pharmafocus - Articles","description":"Discover the latest articles published by Pharmafocus. Browse and customize the article feed to your preferences and explore latest trends","image":"https://cdn.magloft.com/pwa-664/seo/image/e7a95017-d617-4914-b4b3-09fcfc683f75.png","imageAlt":"Pharmafocus - Articles"},"issues":{"title":"Pharmafocus - Magazine Issues","description":"Explore the latest issues of Pharmafocus Magazine and keep up to date with the latest industry knowledge","image":"https://cdn.magloft.com/pwa-664/seo/image/b1c374f3-b368-4654-bf00-3b5ed81fe6c2.png","imageAlt":"Pharmafocus - Issues"},"account":{"title":"Pharmafocus - Account","description":"Manage your Pharmafocus Reader Account..","image":"https://cdn.magloft.com/pwa-664/seo/image/5ad881b1-a927-4fb1-b331-81963e9a0f84.png","imageAlt":"Reader Account"}},"strings":{"app":{"title":"Pharmafocus","subtitle":"Pharmaceutical Industry news, analysis and insights"},"social":{"facebook":null,"twitter":"https://twitter.com/Pharmafocus","linkedin":"https://www.linkedin.com/company/pharmafile","youtube":null,"instagram":null},"topMenu":{"title":null,"subtitle":null},"footerMenu":{"title":"Pharmafocus","subtitle":null,"description":null,"email":["info@pharmafile.com"],"privacyUrl":"https://www.pharmafile.com/privacy-policy","termsUrl":"https://www.pharmafile.com/terms-of-service","links":[{"name":"Pharmafile.com","url":"http://www.pharmafile.com"},{"name":"Pharmafile Magazine","url":"https://magazine.pharmafile.com"},{"name":"Samedan","url":"http://www.samedanltd.com"}]},"pages":null},"customFonts":[{"identifier":"trade-gothic-lt"},{"identifier":"trade-gothic-lt-bold"}],"phrases":{},"trialEndAt":null,"bypassSubscription":false},"publication":{"id":14882,"title":"Pharmafocus","properties":{"subtitle":null,"appIcon":"images/defaults/app-icon.png","promotionalText":null,"companyName":null,"emailReplyTo":"","privacyUrl":null,"termsUrl":null}},"categories":[{"id":43138,"slug":"uk-pharma-news","title":"UK News","color":"#444444","issueCount":3,"articleCount":79,"categoryGroupIds":[]},{"id":43139,"slug":"general-news","title":"General News","color":"#444444","issueCount":3,"articleCount":78,"categoryGroupIds":[]},{"id":43140,"slug":"approvals","title":"Approvals","color":"#444444","issueCount":3,"articleCount":159,"categoryGroupIds":[]},{"id":43141,"slug":"research-and-development","title":"R \u0026 D","color":"#444444","issueCount":1,"articleCount":174,"categoryGroupIds":[]},{"id":43143,"slug":"mergers-acquisitions","title":"Mergers \u0026 Acquisitions","color":"#444444","issueCount":0,"articleCount":69,"categoryGroupIds":[]},{"id":43144,"slug":"manufacturing-production","title":"Manufacturing","color":"#444444","issueCount":1,"articleCount":31,"categoryGroupIds":[]},{"id":43149,"slug":"clinical-trials","title":"Clinical Trials","color":"#444444","issueCount":2,"articleCount":33,"categoryGroupIds":[]},{"id":43145,"slug":"industry-insights","title":"Industry Insights","color":"#444444","issueCount":1,"articleCount":56,"categoryGroupIds":[]},{"id":43146,"slug":"appointments","title":"Appointments","color":"#444444","issueCount":2,"articleCount":87,"categoryGroupIds":[]},{"id":43147,"slug":"insider-interviews","title":"Interviews","color":"#444444","issueCount":0,"articleCount":9,"categoryGroupIds":[]},{"id":43148,"slug":"features","title":"Features","color":"#444444","issueCount":0,"articleCount":20,"categoryGroupIds":[]},{"id":43142,"slug":"industry-facts","title":"Industry Facts","color":"#444444","issueCount":2,"articleCount":23,"categoryGroupIds":[]}],"pwaSubscriptions":[],"categoryGroups":[],"category":{"id":43149,"slug":"clinical-trials","title":"Clinical Trials","description":"Latest updates on clinical trials and their results.","color":"#444444","icon":"symbol-bell","image":"https://cdn.magloft.com/pwa-664/category/image/73869308-54b9-43d7-acf9-fdafa1d07e63.jpg","position":7,"seoDescription":"Latest updates on the digital side of the pharmaceutical industry","categoryGroupIds":[]},"issues":[{"id":52483,"slug":"pharmafocus-october-2024","unlockType":"free","entryArticleSlug":"fda-approves-first-drug-in-50-years-for-treatment-of-schizophren","priceTier":null,"hasPdf":false,"publicationId":14882,"title":"Pharmafocus October 2024","description":"Welcome to the October 2024 edition of Pharmafocus!","date":1728601200000,"updatedAt":1731675001000,"coverUrl":"https://cdn.magloft.com/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg","source":"typeloft2","aspectRatio":0.706,"categoryIds":[43138,43139,43140,43149,43145,43146,43142],"pwaOptinId":null,"pwaSubscriptionIds":[],"classificationIds":[],"sourceFile":"pwa-664/pdf-import/pdf/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.pdf","keywordPhrase":null,"seoDescription":null,"categories":[{"id":43146,"slug":"appointments","title":"Appointments","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43140,"slug":"approvals","title":"Approvals","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43149,"slug":"clinical-trials","title":"Clinical Trials","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43139,"slug":"general-news","title":"General News","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43142,"slug":"industry-facts","title":"Industry Facts","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43145,"slug":"industry-insights","title":"Industry Insights","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43138,"slug":"uk-pharma-news","title":"UK News","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]}],"properties":{"allowPdfDownload":true,"allowRead":true,"pdfOnly":false,"checkoutUrl":null},"screenshots":[]},{"id":52217,"slug":"pharmafocus-september-2024","unlockType":"free","entryArticleSlug":"first-nasal-spray-for-treatment-of-anaphylaxis-approved-by-fda","priceTier":null,"hasPdf":false,"publicationId":14882,"title":"Pharmafocus September 2024","description":"Welcome to the September 2024 issue of Pharmafocus! \nThis issue covers the latest news including new FDA approval for primary biliary cholangitis, NICE recommendations for skyrizi (risankizumab), CHMP opinion on Merck’s KEYTRUDA, as well as articles on precision medicine and oral peptides PLUS what to look out for at this year's CPHI in Milan! ","date":1725577200000,"updatedAt":1725970662000,"coverUrl":"https://cdn.magloft.com/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png","source":"typeloft2","aspectRatio":0.706,"categoryIds":[43138,43139,43140,43149],"pwaOptinId":null,"pwaSubscriptionIds":[],"classificationIds":[],"sourceFile":"pwa-664/pdf-import/pdf/7c2665b2-7a4f-486f-ae94-622756ac873a.pdf","keywordPhrase":null,"seoDescription":"September 2024 issue of Pharmafocus! \nIncluding new FDA approval for primary biliary cholangitis, NICE recommendations for skyrizi (risankizumab), CHMP opinion on KEYTRUDA, articles on precision medicine \u0026 oral peptides PLUS a guide to CPHI in Milan! ","categories":[{"id":43140,"slug":"approvals","title":"Approvals","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43149,"slug":"clinical-trials","title":"Clinical Trials","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43139,"slug":"general-news","title":"General News","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43138,"slug":"uk-pharma-news","title":"UK News","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]}],"properties":{"allowPdfDownload":true,"allowRead":true,"pdfOnly":false,"checkoutUrl":null},"screenshots":[]}],"articles":[{"id":269382,"slug":"aravax-successfully-recruits-for-phase-3-peanut-allergy-treatmen-0fe6","issueId":52826,"categoryIds":[43149],"title":"Aravax successfully recruits for phase 3 peanut allergy treatment study","description":"Clinical-stage biotech company Aravax has announced that it has completed phase 2 recruitment for its precision therapy (pvx108) study, which investigates treatment of peanut allergies.","image":"https://cdn.magloft.com/pdf-import/1144/images/img_10-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269382.jpg?ts=1731583396","date":1731628800000,"unlockType":"free","categories":[{"id":43149,"title":"Clinical Trials","slug":"clinical-trials"}],"pdfPageId":"dMJ3L2BUSaSt","visible":true,"showOnToc":true,"bookmark":false,"position":17},{"id":269383,"slug":"chiesi-announces-phase-3-results-from-enzyme-replacement-study-c996","issueId":52826,"categoryIds":[43149],"title":"Chiesi announces phase 3 results from enzyme-replacement study","description":"Chiesi Global Rare Diseases has announced the results from its BRIGHT trial, which evaluates the efficacy of enzyme-replacement therapy drug elfabrio at twice the approved dose in patients who have been treated with agalsidase alfa or beta. The current approved dose of pegunigalside alfa-iwxj (elfabrio) is 1 milligram (mg) per kilogram (kg) administered every two weeks.","image":"https://cdn.magloft.com/pdf-import/1144/images/img_10-2.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269383.jpg?ts=1731683698","date":1731628800000,"unlockType":"free","categories":[{"id":43149,"title":"Clinical Trials","slug":"clinical-trials"}],"pdfPageId":null,"visible":true,"showOnToc":true,"bookmark":false,"position":18},{"id":269384,"slug":"valiant-phase-3-trial-results-highlight-potential-treatment-for-f577","issueId":52826,"categoryIds":[43149],"title":"VALIANT phase 3 trial results highlight potential treatment for rare kidney diseases","description":"Sobi and Apellis Pharmaceuticals have announced the results from the VALIANT trial, which highlight that systemic pegcetacoplan treatment could benefit patients with c3 glomerulopathy (c3g) and primary immune complex membranoproliferative glomerulonephritis (ic-mpgn).","image":"https://cdn.magloft.com/pdf-import/1144/images/pages/pg-011.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269384.jpg?ts=1731683618","date":1731628800000,"unlockType":"free","categories":[{"id":43149,"title":"Clinical Trials","slug":"clinical-trials"}],"pdfPageId":null,"visible":true,"showOnToc":true,"bookmark":false,"position":19},{"id":269385,"slug":"rallybio-s-application-for-a-phase-2-trial-in-pregnant-women-app-1387","issueId":52826,"categoryIds":[43149],"title":"Rallybio’s application for a phase 2 trial in pregnant women approved","description":"Clinical-stage biotech company Rallybio corporation has announced that it has received approval from two regulatory bodies for its clinical trial applications (CTAS) for a phase 2 study involving pregnant women.","image":"https://cdn.magloft.com/pdf-import/1144/images/img_11-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269385.jpg?ts=1731683519","date":1731628800000,"unlockType":"free","categories":[{"id":43149,"title":"Clinical Trials","slug":"clinical-trials"}],"pdfPageId":null,"visible":true,"showOnToc":true,"bookmark":false,"position":20},{"id":262730,"slug":"verisense-announce-opening-of-digital-biobank","issueId":52217,"categoryIds":[43138,43139,43149],"title":"Verisense announce opening of Digital Biobank","description":"This month, Verisense have announced that their digital biobank, with data from over one million people, is open for business.","image":"https://cdn.magloft.com/pdf-import/1110/images/img_5-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/262730.jpg?ts=1725629295","date":1725577200000,"unlockType":"free","categories":[{"id":43149,"title":"Clinical Trials","slug":"clinical-trials"},{"id":43139,"title":"General News","slug":"general-news"},{"id":43138,"title":"UK News","slug":"uk-pharma-news"}],"pdfPageId":"BkEyq2EaGSXX","visible":true,"showOnToc":true,"bookmark":false,"position":11},{"id":262746,"slug":"dive-into-the-heart-of-pharma-at-cphi-milan-2024","issueId":52217,"categoryIds":[43138,43139,43140,43149],"title":"Dive into the heart of pharma at CPHI Milan 2024","description":"Join us at CPHI Milan 2024, the premier global event for pharmaceutical professionals, from 8-10 October at Fiera Milano, Milan, Italy. Celebrating 35 years of excellence, this event promises unparalleled opportunities for networking, innovation and professional growth. With over 62,000 attendees and 2,500 exhibitors, you’ll experience insightful seminars, cutting-edge exhibitions and new awards such as ‘Woman of the Year’ and ‘Future Leader’. ","image":"https://cdn.magloft.com/pdf-import/1110/images/img_16-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/262746.jpg?ts=1725631252","date":1725577200000,"unlockType":"free","categories":[{"id":43140,"title":"Approvals","slug":"approvals"},{"id":43149,"title":"Clinical Trials","slug":"clinical-trials"},{"id":43139,"title":"General News","slug":"general-news"},{"id":43138,"title":"UK News","slug":"uk-pharma-news"}],"pdfPageId":"Hfjj32dCYbNj","visible":true,"showOnToc":true,"bookmark":false,"position":28},{"id":253520,"slug":"fda-approves-skin-cancer-ai-detection-device","issueId":51075,"categoryIds":[43149],"title":"FDA approves skin cancer AI detection device","description":"DermaSensor has announced that the FDA has granted clearance for its real-time, non-invasive skin cancer evaluation system.","image":"https://cdn.magloft.com/pdf-import/1002/images/img_2-3.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/253520.jpg?ts=1707302098","date":1707264000000,"unlockType":"free","categories":[{"id":43149,"title":"Clinical Trials","slug":"clinical-trials"}],"pdfPageId":"mB8Wj2ZXbaSb","visible":true,"showOnToc":true,"bookmark":false,"position":3},{"id":253526,"slug":"digital-healthcare-platform-launched-by-eli-lilly","issueId":51075,"categoryIds":[43149],"title":"Digital healthcare platform launched by Eli Lilly","description":"Eli Lilly has announced its new digital healthcare experience, LillyDirect, which will benefit patients in the US with obesity, migraine and diabetes. This is intended to offer resources around disease management, such as access to healthcare providers, tailored support and delivery of selected medications.","image":"https://cdn.magloft.com/pdf-import/1002/images/img_4-2.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/253526.jpg?ts=1707302677","date":1707264000000,"unlockType":"free","categories":[{"id":43149,"title":"Clinical Trials","slug":"clinical-trials"}],"pdfPageId":"klZ50UEQdrJb","visible":true,"showOnToc":true,"bookmark":false,"position":9},{"id":223630,"slug":"nice-recommends-nine-digital-treatment-options-for-depression-and-anxiety","issueId":49396,"categoryIds":[43149],"title":"NICE recommends nine digital treatment options for depression and anxiety","description":"The National Institute for Health and Care Excellence (NICE) has recommended six digitally enabled therapies for adult patients with anxiety disorders and three digitally enabled therapies for adult patients with depression for use within the NHS while further data is gathered.","image":"https://cdn.magloft.com/pdf-import/850/images/img_2-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/223630.jpg?ts=1688410309","date":1688338800000,"unlockType":"free","categories":[{"id":43149,"title":"Clinical Trials","slug":"clinical-trials"}],"pdfPageId":"NrKdHrz2hpIK","visible":true,"showOnToc":true,"bookmark":false,"position":3},{"id":223655,"slug":"servier-and-aitia-enter-into-r-d-collaboration-for-pancreatic-ca","issueId":49396,"categoryIds":[43149],"title":"Servier and Aitia enter into R\u0026D collaboration for pancreatic cancer using Digital Twins","description":"French pharmaceutical company Servier and US-based causal AI and digital twins company Aitia have announced a collaboration to create digital twins as an aid to help treat pancreatic cancer. This collaboration builds on a previous multiple myeloma one that was announced in 2022.","image":"https://cdn.magloft.com/pdf-import/850/images/pages/pg-011.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/223655.jpg?ts=1688469081","date":1688338800000,"unlockType":"free","categories":[{"id":43149,"title":"Clinical Trials","slug":"clinical-trials"}],"pdfPageId":"Dd5qtZuOBQiG","visible":true,"showOnToc":true,"bookmark":false,"position":29},{"id":208440,"slug":"bristol-myers-squibb-and-viz-ai-sign-multi-year-partnership-for","issueId":48654,"categoryIds":[43149],"title":"Bristol Myers Squibb and Viz.ai sign multi-year partnership for HCM device","description":"Bristol Myers Squibb and Viz.ai, an AI-powered medical imaging company, have signed a deal to use AI to detect and triage patients with suspected hypertrophic cardiomyopathy (hcm).","image":"https://cdn.magloft.com/pdf-import/771/images/pages/pg-012.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/208440.jpg?ts=1680776706","date":1680476400000,"unlockType":"free","categories":[{"id":43149,"title":"Clinical Trials","slug":"clinical-trials"}],"pdfPageId":"LRMYcxOip5xg","visible":true,"showOnToc":true,"bookmark":false,"position":31},{"id":208441,"slug":"sooma-receives-fda-breakthrough-device-designation-for-depressio","issueId":48654,"categoryIds":[43149],"title":"Sooma receives FDA Breakthrough Device designation for depression therapy device","description":"Finnish company Sooma medical has received breakthrough device designation by the FDA for its portable, at-home neuromodulation device to treat depression.","image":"https://cdn.magloft.com/pdf-import/771/images/pages/pg-012.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/208441.jpg?ts=1680776769","date":1680476400000,"unlockType":"free","categories":[{"id":43149,"title":"Clinical Trials","slug":"clinical-trials"}],"pdfPageId":"LRMYcxOip5xg","visible":true,"showOnToc":true,"bookmark":false,"position":33}]},"__N_SSG":true},"page":"/domains/[domain]/categories/[slug]","query":{"domain":"www.pharmafocus.com","slug":"clinical-trials"},"buildId":"U1LT7ce93wR6IyWFJCllT","isFallback":false,"gsp":true,"scriptLoader":[]}</script></body></html>

Pages: 1 2 3 4 5 6 7 8 9 10